Dr. Toto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-1919Fax+1 214-645-1903
Education & Training
University of Texas Southwestern Medical CenterFellowship, Nephrology, 1982 - 1983
Baylor College of MedicineResidency, Internal Medicine, 1979 - 1980
University of MichiganResidency, Internal Medicine, 1977 - 1979
University of Illinois College of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 1980 - Present
TX State Medical License 1983 - 2025- TX State Medical License 1980 - 2023
TN State Medical License 1997 - 1998
MI State Medical License 1978 - 1982- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure Start of enrollment: 1999 Feb 01
- Improving Outcomes in Patients With Kidney Disease Due to Diabetes Start of enrollment: 2003 Jul 01
- African American Study of Kidney Disease and Hypertension ABPM Pilot Study Start of enrollment: 2007 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 699 citationsEffect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinica...Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E. Cooper, Steven E. Kahn
JAMA. 2019-01-01 - 629 citationsBardoxolone Methyl and Kidney Function in CKD with Type 2 DiabetesPablo E. Pergola, Philip Raskin, Robert D. Toto, Colin J. Meyer, J. Warren Huff
The New England Journal of Medicine. 2011-07-27 - 244 citationsEffects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis f...David C. Wheeler, Bergur V. Stefánsson, Niels Jongs, Glenn M. Chertow, Tom Greene
The Lancet. Diabetes & Endocrinology. 2021-01-01
Journal Articles
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal RiskSteven E Kahn, John H Alexander, Robert D Toto, Darren K McGuire, JAMA
Grant Support
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2011
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2011
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2011
- North And Central Texas Clinical And Translational Science Initiative (UL1)National Center For Research Resources2010–2011
- North And Central Texas Clinical And Translational Science Initiative (TL1)National Center For Research Resources2010–2011
- North And Central Texas Clinical And Translational Science Initiative (KL2)National Center For Research Resources2010–2011
- Mentoring Program For Clinical Researchers In NephrologyNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2010
- Improving Outcomes In Diabetic NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2008
- Training Curriculum In Patient Oriented ResearchNational Center For Research Resources2005–2007
- AASK And Hypertension Cohort StudyNational Center For Research Resources2005–2007
- Improving Outcomes In Diabetic NephropathyNational Center For Research Resources2004–2007
- African American Study Of Kidney Disease And Hypertensi*National Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
- Role Of The Calcium Sensing Receptor In Regulation Of SALT Balance And BPNational Center For Research Resources2004
- African-American Study Of Kidney Disease (Aask)-HypertensionNational Center For Research Resources2004
- Training Curriculum In Patient Oriented ResearchNational Heart, Lung, And Blood Institute2001–2004
- African American Study Of Kidney Disease And HypertensioNational Institute Of Diabetes And Digestive And Kidney Diseases1994–2002
- Mortality And Morbidity In HemodialysisNational Institute Of Diabetes And Digestive And Kidney Diseases1994–2001
- Lipoprotein Metabolism In Diabetic NephropathyNational Center For Research Resources1998–1999
- African American Study Of Kidney Disease &HypertensionNational Institute Of Diabetes And Digestive And Kidney Diseases1997
- Renal Effects Of RamiprilNational Center For Research Resources1995–1997
- African American Study Of Kidney Disease And HypertensionNational Center For Research Resources1996
- Pilot Study--African American Study Of Kidney DiseaseNational Center For Research Resources1995
- Nephrotic Syndrome--Cause Of Cholesterol Ester Enrichment In APO BNational Center For Research Resources1995
- Lipoprotein Metabolism In Diabetic Nephropathy--Role Of ProteinuriaNational Center For Research Resources1995
- Kidney Disease And Hypertension--Pilot StudyNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- Kidney Disease And Hypertension In Blacks: A Pilot StudyNational Institute Of Diabetes And Digestive And Kidney Diseases1993
- Kidney Disease And Hypertension In Blacks--A Pilot StudyNational Institute Of Diabetes And Digestive And Kidney Diseases1992
- Renal Physiology And Metabolism Of Novel EicosanoidsNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
